Loriaut Patrick, Nordmann Jean-Philippe, Laroche Laurent, Borderie Vincent M
*Department of Ophthalmology, Centre Hospitalier National d'Ophtalmologie des XV-XX, Paris, France; and †Department of Ophthalmology, Pierre & Marie Curie University Paris 06, Research Team 968, Institut de la Vision, Paris, France.
Cornea. 2015 Apr;34(4):375-80. doi: 10.1097/ICO.0000000000000367.
The aim of this study was to compare deep sclerectomy to trabeculectomy in eyes with penetrating keratoplasty (PK).
In a retrospective comparative case series, 32 consecutive deep sclerectomies (deep sclerectomy group) and 32 matched trabeculectomies (trabeculectomy group) were performed in eyes with PK. Control cases were matched for the timing of glaucoma surgery, number of previous glaucoma surgical procedures, corneal disease, and lens status. The main outcome measures were the success rate of glaucoma surgery and graft survival. Intraocular pressure, graft transparency, and postoperative complications were recorded. The criteria for glaucoma surgery failure were a postoperative intraocular pressure higher than 21 mm Hg or a decrease lower than 30%.
The average follow-up time of glaucoma surgery was 29 ± 30 months. No significant differences were observed between both groups for all baseline variables and postoperative follow-up time. The success rate of glaucoma surgery was, respectively, 76% and 44% at 1 and 5 years in the deep sclerectomy group and 69% and 49% in the trabeculectomy group (P = 0.69). The graft survival estimates were, respectively, 100% and 73% at 1 and 5 years in the deep sclerectomy group and 87% and 40% in the trabeculectomy group (P = 0.02). Nonimmune postoperative events and nonimmune graft failures were significantly more frequent in the trabeculectomy group compared with the deep sclerectomy group (P = 0.04).
Graft survival was higher in eyes with deep sclerectomy compared with trabeculectomy. Deep sclerectomy seems as efficient as, but safer than, trabeculectomy and could be performed as a first-choice treatment in the absence of major peripheral anterior synechiae.
本研究旨在比较穿透性角膜移植术(PK)眼行深层巩膜切除术与小梁切除术的效果。
在一项回顾性比较病例系列研究中,对连续32例行深层巩膜切除术的PK眼(深层巩膜切除术组)和32例匹配的小梁切除术的PK眼(小梁切除术组)进行了研究。对照病例在青光眼手术时间、既往青光眼手术次数、角膜疾病和晶状体状态方面进行了匹配。主要观察指标为青光眼手术成功率和移植物存活率。记录眼压、移植物透明度和术后并发症。青光眼手术失败的标准为术后眼压高于21 mmHg或眼压降低低于30%。
青光眼手术的平均随访时间为29±30个月。两组在所有基线变量和术后随访时间方面均未观察到显著差异。深层巩膜切除术组1年和5年的青光眼手术成功率分别为76%和44%,小梁切除术组分别为69%和49%(P = 0.69)。深层巩膜切除术组1年和5年的移植物存活率估计分别为100%和73%,小梁切除术组分别为87%和40%(P = 0.02)。与深层巩膜切除术组相比,小梁切除术组非免疫性术后事件和非免疫性移植物失败明显更频繁(P = 0.04)。
与小梁切除术相比,深层巩膜切除术的移植物存活率更高。深层巩膜切除术似乎与小梁切除术一样有效,但更安全,在没有严重周边前粘连的情况下可作为首选治疗方法。